Frequency Of Metabolic Syndrome In Patients With Psoriasis

Area of Science:

• Dermatology
• Metabolic Health
• Public Health

Background:

• Psoriasis is an inflammatory skin condition linked to systemic comorbidities.
• Metabolic syndrome, characterized by a cluster of risk factors, is increasingly recognized in psoriasis patients.
• Understanding the frequency of metabolic syndrome in psoriasis is crucial for comprehensive patient care.

Purpose of the Study:

• To determine the prevalence of metabolic syndrome among individuals diagnosed with psoriasis.
• To investigate potential differences in metabolic syndrome frequency between male and female psoriasis patients.

Main Methods:

• A cross-sectional study involving 80 psoriasis patients was conducted.
• Data collected included blood pressure, waist circumference, body surface area, Psoriasis Area Severity Index, fasting blood sugar, serum triglyceride, and HDL cholesterol.
• Metabolic syndrome was diagnosed based on the modified National Cholesterol Education Program Adult Panel III criteria (≥3 out of 5).

Main Results:

• Nearly half of the psoriasis patients (48.8%) met the criteria for metabolic syndrome.
• Female patients exhibited a higher prevalence of metabolic syndrome (72.2%) compared to males (41.9%).
• A statistically significant difference in mean Body Mass Index (BMI) was observed between females (28.3) and males (26.0), with a positive correlation between body surface area and BMI.

Conclusions:

• Metabolic syndrome is frequently observed in patients with psoriasis.
• Female psoriasis patients demonstrate a significantly higher frequency of metabolic syndrome and tend to have a higher BMI.